Journal Mobile Options
Table of Contents
Vol. 48, No. 1, 2004
Issue release date: January–February 2004

Obesity Indices and Major Components of Metabolic Syndrome in Young Adult Arab Subjects

Al-Shayji I.A.R. · Akanji A.O.
To view the fulltext, log in and/or choose pay-per-view option

Individual Users: Register with Karger Login Information

Please create your User ID & Password

Contact Information

I have read the Karger Terms and Conditions and agree.

To view the fulltext, please log in

To view the pdf, please log in


Background: The major components of metabolic syndrome are atherogenic dyslipidaemia (AD) and insulin resistance (IR), and both predict risk for atherosclerotic cardiovascular disease even in healthy individuals. Aims: To assess if, in a group of healthy young adult Arab subjects, a simple classification in high and normal scores on waist-hip ratio (WHR), body mass index (BMI) and waist circumference (WC) scales could predict atherogenic parameters for metabolic syndrome (AD, IR). Subjects and Methods: The subjects [n = 177 (72 M, 105 F), aged 29.7 ± 8.4 (SD) years], underwent physical evaluation, BP measurement and anthropometry [height (m), weight (kg), waist (WC) and hip circumference (HC, cm)]. The cut-off points for normal/high scores on the indices were: (1) BMI: 30 kg/m2 (M and F); (2) WHR: 0.80 F, 0.95 M, and (3) WC: 90 cm F, 100 cm M). The biochemical indices measured on fasting serum were: (1) AD: total cholesterol (TC), triglycerides (TG), HDL, LDL, apo B, HDL/TC ratio, and (2) IR: insulin, urate, insulin/glucose ratio (IGR). Results and Discussion: In the whole group of subjects, and in women separately considered, those with high indices (BMI, WHR, WC) had significantly increased levels of glucose, LDL, apo B, urate, mean BP, TG, insulin and IGR and lower values for HDL/TC ratio (all p < 0.05). In men, only urate, insulin and IGR levels were increased (p < 0.01) in the high-score groups. None of the indices showed any special superiority in describing the risk of AD or IR. Conclusion: In women, BMI, WHR and WC appeared equally good in identifying individuals at high risk of AD and IR while in men, these indices satisfactorily described the risk of IR but not of AD. It is important to re-emphasise the need to indicate gender distinctions in using anthropometry for CHD risk assessment.

Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.


  1. World Health Organization: Obesity: Preventing and managing the global epidemic. World Health Organ Tech Rep Ser 2000;894.
  2. Kumanyika S, Jeffery RW, Morabia C, Antipatis VJ: Obesity prevention: The case for action. Int J Obes 2002;26:425–436.

    External Resources

  3. Al-Isa AN: Prevalence of obesity among adult Kuwaitis: A cross-sectional study. Int J Obes 1995;19:431–433.
  4. Al-Isa AN: Temporal changes in body mass index and prevalence of obesity among Kuwaiti men. Ann Nutr Metab 1997;41:307–314.
  5. Al-Isa AN, Moussa MA: Obesity among Kuwaiti pre-school children aged 0–5 years: Prevalence and comparison with the NCHS/CDC reference population. Nutr Health 1998;12:235–246.
  6. Deckelbaum RJ, Williams CL: Childhood obesity: The health issue. Obes Rev 2001;9(suppl 4):239S–243S.
  7. Strauss RS, Pollock HA: Epidemic increase in childhood overweight 1986–1988. JAMA 2001;286:2845–2848.
  8. Rocchini AP: Childhood obesity and a diabetes epidemic. N Engl J Med 2002;346:854–855.
  9. Sinha R, Fisch G, Teague B, Tamborlane WV, Banyas B, Allen K, Savoye M, Rieger V, Taksali S, Barbetta G, Sherwin RS, Caprio S: Prevalence of impaired glucose tolerance among children and adolescents with marked obesity. N Engl J Med 2002;346:802–810.
  10. Reaven G: Role of insulin resistance in human disease. Diabetes 1988;37:1595–1607.
  11. Groop L, Orho-Melander M: The dysmetabolic syndrome. J Intern Med 2001;250:105–120.
  12. Seidell JC, Flegal KM: Assessing obesity: Classification and epidemiology. Br Med Bull 1997;53:238–252.
  13. Despres JP: Health consequences of visceral obesity. Ann Med 2001;33:534–541.
  14. Little P, Bryne CD: Abdominal obesity and the ‘hypertriglyceridaemic waist’ phenotype. BMJ 2001;322:687–689.
  15. Lean ME, Tan TS, Morrison CE: Waist circumference as a measure for indicating need for weight management. BMJ 1995;311:158–161.
  16. Despres J-P, Lemieux I, Prud’homme D: Treatment of obesity: Need to focus on high-risk, abdominally obese patients. BMJ 2002;322:716–720.
  17. Friedewald WT, Levy RI, Frederickson DS: Estimation of the concentration of low-density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Clin Chem 1972;18:499–502.
  18. DeFronzo R, Ferrannini E: Insulin resistance. A multifacet syndrome responsible for NIDDM, obesity, hypertension, dyslipidaemia and atherosclerotic cardiovascular disease. Diabetes Care 1991;14:173–194.
  19. Haffner S, Valdez R, Hazuda H, Mitchell B, Morales P, Stern M: Prospective analysis of the insulin resistance syndrome. Diabetes 1992;41:715–722.
  20. Han TS, van Leer EM, Seidell JC, Lean ME: Waist circumference action levels in the identification of cardiovascular risk factors: Prevalence study in a random sample. BMJ 1995;311:1401–1405.
  21. Visscher TL, Seidell JC, Molarius A, van der Kuip D, Hofman A, Witteman JC: A comparison of body mass index, waist-hip ratio and waist circumference as predictors of all-cause mortality among the elderly: The Rotterdam study. Int J Obes 2001;25:1730–1735.
  22. Sattar N, Tan CE, Han TS, Forster L, Lean ME, Shepherd J, Packard CJ: Associations of indices of adiposity with atherogenic lipoprotein subfractions. Int J Obes 1998;22:432–439.
  23. Dobbelsteyn CJ, Joffres MR, MacLean DR, Flowerdew G: A comparative evaluation of waist circumference, waist-to-hip ratio and body mass index as indicators of cardiovascular risk factors. The Canadian Heart Health Surveys. Int J Obes 2001;25:652–661.
  24. Yasmin, Mascie-Taylor CG: Adiposity indices and their relationship with some risk factors of coronary heart disease in middle-aged Cambridge men and women. Ann Hum Biol 2000;27:239–248.
  25. Ko GT, Chan JC, Woo J, Lau E, Yeung VT, Chow CC, Wai HP, Li JK, So WY, Cockram CS: Simple anthropometric indexes and cardiovascular risk factors in Chinese. Int J Obes 1997;21:995–1001.

Pay-per-View Options
Direct payment This item at the regular price: USD 38.00
Payment from account With a Karger Pay-per-View account (down payment USD 150) you profit from a special rate for this and other single items.
This item at the discounted price: USD 26.50